Status:
UNKNOWN
Estrogen Treatment in Acromegalic Women
Lead Sponsor:
Université de Montréal
Collaborating Sponsors:
Novartis
Conditions:
Acromegaly
Eligibility:
FEMALE
18+ years
Phase:
PHASE2
Brief Summary
Oral estrogens may be an effective adjuvant treatment for control of acromegaly in patients with resistance to somatostatin analogs.
Detailed Description
This will be a canadian multicenter study with a randomized, double-blind, placebo-controlled design, to assess the efficacy and safety of adjuvant alesse in female acromegalic patients with suboptima...
Eligibility Criteria
Inclusion
- Women 18 years and older treated with somatostatin analogs
- Active acromegaly
Exclusion
- Cardiovascular or cerebrovascular disease
- Thrombophlebitis or thromboembolism
- Breast cancer
- Non-controlled arterial hypertension
- Smoking
- Pregnancy or lactation
Key Trial Info
Start Date :
May 1 2006
Trial Type :
INTERVENTIONAL
End Date :
August 1 2007
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00315107
Start Date
May 1 2006
End Date
August 1 2007
Last Update
May 26 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHUM - Notre-Dame Hospital
Montreal, Quebec, Canada, H2L 4M1